<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:department>Inst of Molecular &amp; Cellular Biology</gtr:department><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3FB421B3-7C2F-4138-A021-900EFA4C7508"><gtr:id>3FB421B3-7C2F-4138-A021-900EFA4C7508</gtr:id><gtr:firstName>Hugh</gtr:firstName><gtr:surname>Pearson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D9A41FBF-06A7-4FBD-A4CC-2FA39D4D3A35"><gtr:id>D9A41FBF-06A7-4FBD-A4CC-2FA39D4D3A35</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Peers</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0600936"><gtr:id>F3323D3B-BE19-4249-BAD4-520099AEB1F1</gtr:id><gtr:title>Altered Expression of Ion Channels in Alzheimer s disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600936</gtr:grantReference><gtr:abstractText>In Alzheimer s disease there is a build-up of protein in the brain that is thought to cause the death of nerve cells. We have found that this protein, named amyloid beta protein (Abeta), causes changes in the electrical activity of nerve cells when in a form that is not usually associated with the disease. In fact, we suspect that this may be a normal function of the protein. We believe that during the disease process Abeta] may lose its ability to alter electrical activity and this leads to death of nerve cells. This idea needs to be tested and to do this we will measure the effects of normal Abeta and abnormal Abeta on the electrical activity of individual nerve cells. In separate experiments we will also be able to track changes in levels of proteins involved in causing electrical activity in nerve cells (ion channels), and view their position within the nerve cells. This will give us more detailed information on the changes that occur and their consequences during the disease.
Because we believe that changes in protein will result in nerve cell death we will also look at how ion channel activity changes in nerve cells that are just beginning to enter the cell death death process. This will allow us to directly measure differences between the electrical activity of nerve cells that are healthy and those that are not. The information gained from these experiments will tell us how important changes in electrical activity in the brain of Alzheimer s disease patients are in causing the death of the nerve cells. This is vitally important since, unlike almost all other cell types, nerve cells do not divide and replace themselves. If we can prevent the cell death caused by Abeta we may therefore be able to slow or halt the progression of Alzheimer s disease.</gtr:abstractText><gtr:technicalSummary>Recent evidence from a number of sources implicates a role for ion channels in Alzheimer s disease. We have evidence suggesting that the main constituent of senile plaques, amyloid beta protein (Abeta), has a profound effect on ion channel expression in central neurones. In this proposal we hypothesise that Abeta acts as a physiological mediator of ion channel expression and loss of this function by aggregation/oligomerisation in Alzheimer s disease results in neurotoxicty. In order to test this idea we will measure ion channel currents (primarily K+ and Ca2+) and action potential parameters (amplitude, duration, afterhyperpolarisation, firing rates) in mouse hippocampal slices that have been treated for varying lengths of time with different forms of Abeta that are implicated in either AD or in normal function (monomeric, oligomeric and aggregated Abeta). Experiments will require application of Abeta peptides prepared from cells engineered to secrete Abeta (7PA2 cells) to slices (acutely pepared or organotypic) for times varying from 1-48 hours. The effects of inhibiting or increasing Abeta production in slices using pharmacological means (inhibitors of beta- and gamma-secretase and neprilysin) and shRNAi technology will be measured in voltage clamp and current clamp experiments in order to determine the effects of altering endogenous Abeta production on ion channel expression. To compliment patch-clamp study of functional ion channel expression we will use western blot to measure levels of ion channel subunits and immunohistochemistry to localise changes in subcellular distribution of ion channels.

The mechanism by which Abeta alters ion channel activity will be investigated and we will concentrate primarily on the signaling pathway that gives rise to inhibition of long term potentiation in slices. The relevance of changes in ion channel expression to cell death in Alzheimer s disease will be investigated by imaging neurons in the earliest stages of apoptosis with annexin 5. This will allow these neurons to be patched and ion channel currents measured. These experiments will be carried out in slices treated with Abeta or in slices or acutely dissociated neurones prepared from a triple transgenic mouse model of Alzheimer s disease.

These data will provide information on some of the basic mechanisms involved in the neurodegeneration associated with the Alzheimer s disease process. Furthermore, they will allow us to define the role of ion channels in that process and identify the ionic currents that may be involved in cell death or neuroprotective responses.</gtr:technicalSummary><gtr:fund><gtr:end>2010-08-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>380800</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine and Health</gtr:department><gtr:description>Peers/Pearson lab partnership</gtr:description><gtr:id>D2DA70D8-E203-4B3C-A6BD-6964653BC2F9</gtr:id><gtr:impact>PMIDs - 19860837 19845619 19197268 18463498 18381653 17927959 17705799 17428968 17170042 16809372 16686433 16683717 16603928 16464656 16271805 16256194 20573603</gtr:impact><gtr:partnerContribution>Amyloid beta peptide ELISA Generation of alpha synuclein cell lines</gtr:partnerContribution><gtr:piContribution>neuronal cell culture, brain slice recordings, cell death assays</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>ART public meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5FA00396-4126-4B4C-BD29-474A70CC5574</gtr:id><gtr:impact>Lectures/presentations to the public on Alzheimer's disease

200+ attendees from general public</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview Daily mail</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DE4DFA5E-C1D2-4DB6-8043-8CE41925AF04</gtr:id><gtr:impact>Interviewed by daily Mail on Alzheier's disease

Article in Daily Mail, 27th February 2007 'How Alzheimer's disease slowly steals your life aaway'</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British science Festival Bradford</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5C16AA88-6F61-4AE8-8149-CB9A5684C3AC</gtr:id><gtr:impact>Approx. 40 members of the public met to view video and hear about current understanding of Alzheimer's disease

40 members of the public engaged in discussion of AD treatment, future treatments and experiences of AD.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview BBC</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5155053D-D694-40F7-860C-D73F50CC4466</gtr:id><gtr:impact>Interview for BBC news website

BBC news website article: http://news.bbc.co.uk/1/hi/health/6713163.stm</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://news.bbc.co.uk/1/hi/health/6713163.stm</gtr:url><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>140000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alzheimer's Society Project Grant</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Alzheimer?s Society</gtr:fundingOrg><gtr:id>C2E93DBE-FD56-4194-9C6E-0C018A458A4F</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ART Equipment Grant</gtr:description><gtr:end>2008-08-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>D3C0EA8C-DE5A-4354-AC28-6EAD84299342</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/585DDB3A-182B-429C-8254-740EF9AC8510"><gtr:id>585DDB3A-182B-429C-8254-740EF9AC8510</gtr:id><gtr:title>Hypoxia suppresses astrocyte glutamate transport independently of amyloid formation.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0c5c82b40122b1d3beb3d8e68e0406f8"><gtr:id>0c5c82b40122b1d3beb3d8e68e0406f8</gtr:id><gtr:otherNames>Boycott HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F3401128-855B-4F42-8D29-DA0062E39EE1"><gtr:id>F3401128-855B-4F42-8D29-DA0062E39EE1</gtr:id><gtr:title>Hypoxia and Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Essays in biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e7cd5671783201d835e77d68ebb957a"><gtr:id>1e7cd5671783201d835e77d68ebb957a</gtr:id><gtr:otherNames>Peers C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0071-1365</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/504D2E07-AD6D-480C-9F4F-F2D16C7BEE81"><gtr:id>504D2E07-AD6D-480C-9F4F-F2D16C7BEE81</gtr:id><gtr:title>Amyloid beta peptide as a physiological modulator of neuronal 'A'-type K+ current.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d09c265b717b6efd09b6e42ab20b31ae"><gtr:id>d09c265b717b6efd09b6e42ab20b31ae</gtr:id><gtr:otherNames>Plant LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/11E5712D-38F3-4DB4-A691-3A90D2A4CCEF"><gtr:id>11E5712D-38F3-4DB4-A691-3A90D2A4CCEF</gtr:id><gtr:title>Hypoxic regulation of Ca2+ signalling in astrocytes and endothelial cells.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e7cd5671783201d835e77d68ebb957a"><gtr:id>1e7cd5671783201d835e77d68ebb957a</gtr:id><gtr:otherNames>Peers C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FFF2A514-57E6-4C89-8B4C-93F95C58A807"><gtr:id>FFF2A514-57E6-4C89-8B4C-93F95C58A807</gtr:id><gtr:title>Differential involvement of TNF alpha in hypoxic suppression of astrocyte glutamate transporters.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0c5c82b40122b1d3beb3d8e68e0406f8"><gtr:id>0c5c82b40122b1d3beb3d8e68e0406f8</gtr:id><gtr:otherNames>Boycott HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/02AE79FA-E676-4EF2-9F65-F8A34B31460E"><gtr:id>02AE79FA-E676-4EF2-9F65-F8A34B31460E</gtr:id><gtr:title>Amyloid peptides mediate hypoxic increase of L-type Ca2+ channels in central neurones.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1cb2e49a15d892924eb1b9abd9cd33d2"><gtr:id>1cb2e49a15d892924eb1b9abd9cd33d2</gtr:id><gtr:otherNames>Webster NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EA6D4733-47D1-42E0-BD80-0598F99B3E68"><gtr:id>EA6D4733-47D1-42E0-BD80-0598F99B3E68</gtr:id><gtr:title>Hypoxia stimulates Ca2+ release from intracellular stores in astrocytes via cyclic ADP ribose-mediated activation of ryanodine receptors.</gtr:title><gtr:parentPublicationTitle>Cell calcium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ab546a1fd5f9b29527b13867df42afb5"><gtr:id>ab546a1fd5f9b29527b13867df42afb5</gtr:id><gtr:otherNames>Aley PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0143-4160</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6652DDF6-2990-483E-A638-35A7BF916622"><gtr:id>6652DDF6-2990-483E-A638-35A7BF916622</gtr:id><gtr:title>Hypoxic regulation of Ca2+ signalling in astrocytes and endothelial cells.</gtr:title><gtr:parentPublicationTitle>Novartis Foundation symposium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e7cd5671783201d835e77d68ebb957a"><gtr:id>1e7cd5671783201d835e77d68ebb957a</gtr:id><gtr:otherNames>Peers C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1528-2511</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CDE14F0C-8BFA-403B-9A13-CA78E7690809"><gtr:id>CDE14F0C-8BFA-403B-9A13-CA78E7690809</gtr:id><gtr:title>Chronic hypoxia inhibits Na+/Ca2+ exchanger expression in cortical astrocytes.</gtr:title><gtr:parentPublicationTitle>Neuroreport</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a75d82eed5bd49e9e060e854079c4c0b"><gtr:id>a75d82eed5bd49e9e060e854079c4c0b</gtr:id><gtr:otherNames>Atkinson L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0959-4965</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BF944ACA-F914-4E74-93E6-CBEF1DAD25DC"><gtr:id>BF944ACA-F914-4E74-93E6-CBEF1DAD25DC</gtr:id><gtr:title>Modulation of 'A'-type K+ current by rodent and human forms of amyloid beta protein.</gtr:title><gtr:parentPublicationTitle>Neuroreport</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/af58cd093969ffce9dc103a503a05b86"><gtr:id>af58cd093969ffce9dc103a503a05b86</gtr:id><gtr:otherNames>Kerrigan TL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0959-4965</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/67DDDDDE-B7AC-4731-920C-BF4C75DCF181"><gtr:id>67DDDDDE-B7AC-4731-920C-BF4C75DCF181</gtr:id><gtr:title>Carbon monoxide protects against oxidant-induced apoptosis via inhibition of Kv2.1.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3776f09a76c138b398a7cdf34ba0e44e"><gtr:id>3776f09a76c138b398a7cdf34ba0e44e</gtr:id><gtr:otherNames>Dallas ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4FB1A278-0425-4E61-928E-01E85B7971DF"><gtr:id>4FB1A278-0425-4E61-928E-01E85B7971DF</gtr:id><gtr:title>alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4fe59b3b25996fa2c4dda055fd2fc8ac"><gtr:id>4fe59b3b25996fa2c4dda055fd2fc8ac</gtr:id><gtr:otherNames>Hettiarachchi NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B1258440-4A40-4D5E-A95C-3C72309F6441"><gtr:id>B1258440-4A40-4D5E-A95C-3C72309F6441</gtr:id><gtr:title>Gap junction-mediated spontaneous Ca(2+) waves in differentiated cholinergic SN56 cells.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4fe59b3b25996fa2c4dda055fd2fc8ac"><gtr:id>4fe59b3b25996fa2c4dda055fd2fc8ac</gtr:id><gtr:otherNames>Hettiarachchi NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6A891BA3-FFA4-45EC-9C5B-DD6101AC88DE"><gtr:id>6A891BA3-FFA4-45EC-9C5B-DD6101AC88DE</gtr:id><gtr:title>Hypoxia suppresses glutamate transport in astrocytes.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e777b0e58339db30282ebc81fed002e8"><gtr:id>e777b0e58339db30282ebc81fed002e8</gtr:id><gtr:otherNames>Dallas M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F53FB3CD-9A39-49A3-BED9-BAF602F04227"><gtr:id>F53FB3CD-9A39-49A3-BED9-BAF602F04227</gtr:id><gtr:title>Calcium channel subtypes--another layer of complexity to an already intricate story.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4d24e9347f9e7da8cce7bdcd5dca0b0b"><gtr:id>4d24e9347f9e7da8cce7bdcd5dca0b0b</gtr:id><gtr:otherNames>Pearson HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E7681E4B-43B9-415B-A390-38BDC6C75420"><gtr:id>E7681E4B-43B9-415B-A390-38BDC6C75420</gtr:id><gtr:title>Robotic multiwell planar patch-clamp for native and primary mammalian cells.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d1c9450099d4f4a9dc57e106cfd7c461"><gtr:id>d1c9450099d4f4a9dc57e106cfd7c461</gtr:id><gtr:otherNames>Milligan CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/24900FA0-99CE-4885-8A52-B1260DA0A66C"><gtr:id>24900FA0-99CE-4885-8A52-B1260DA0A66C</gtr:id><gtr:title>Cellular consequences of the expression of Alzheimer's disease-causing presenilin 1 mutations in human neuroblastoma (SH-SY5Y) cells.</gtr:title><gtr:parentPublicationTitle>Brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c6cef304d58d228003d6160dac8b99c"><gtr:id>8c6cef304d58d228003d6160dac8b99c</gtr:id><gtr:otherNames>Boyle JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8993</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/46CA2118-29E7-452A-9898-A3E3923AE1D9"><gtr:id>46CA2118-29E7-452A-9898-A3E3923AE1D9</gtr:id><gtr:title>Physiological roles for amyloid beta peptides.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4d24e9347f9e7da8cce7bdcd5dca0b0b"><gtr:id>4d24e9347f9e7da8cce7bdcd5dca0b0b</gtr:id><gtr:otherNames>Pearson HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9E120A5E-A58F-42E1-8D1C-D9899C2F601C"><gtr:id>9E120A5E-A58F-42E1-8D1C-D9899C2F601C</gtr:id><gtr:title>Molecular properties of lysine dendrimers and their interactions with A?-peptides and neuronal cells.</gtr:title><gtr:parentPublicationTitle>Current medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/654d1ceac26295c48d127a0d0c2d5922"><gtr:id>654d1ceac26295c48d127a0d0c2d5922</gtr:id><gtr:otherNames>Neelov IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0929-8673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8E353A46-887B-44A2-B84A-CD18FF871B6A"><gtr:id>8E353A46-887B-44A2-B84A-CD18FF871B6A</gtr:id><gtr:title>Hypoxia and neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e7cd5671783201d835e77d68ebb957a"><gtr:id>1e7cd5671783201d835e77d68ebb957a</gtr:id><gtr:otherNames>Peers C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600936</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>